September 24, 2016 8:29 PM ET

Biotechnology

Company Overview of PDL BioPharma, Inc.

Executive Profile

Stephen J. Hoffman M.D., Ph.D.

Senior Advisor, PDL BioPharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 16 different industries.

See Board Relationships
62--

Background

Dr. Stephen J. Hoffman, also known as Steve, M.D., Ph.D., serves as the President of 10x Capital, Inc. Dr. Hoffman has been a Senior Advisor of PDL BioPharma, Inc. since February 03, 2014. He served as the Managing Director of Skyline Ventures since joining in May 2007. Prior to joining Skyline, Dr. Hoffman served as a General Partner of TVM Capital GmbH from January 2003 to March 2007. He served as the General Partner of TVM V Life Science Ventures. He served as an ...

Corporate Headquarters

932 Southwood Boulevard
Incline Village, Nevada 89451

United States

Phone: 775-832-8500
Fax: 775-832-8501

Board Members Memberships

Director
1994-Present
Chairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee
2007-Present
Director, Member of Audit Committee and Member of Compensation Committee
2010-Present
Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
2010-Present
Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2016-Present
Chairman

Education

PhD
Northwestern University
MD
University of Colorado School of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John W. Varian Chief Executive Officer and Director
XOMA Corporation
$586.6K
Michael S. O. Oredsson B.Int’l Bus Admin (Lund)Chief Executive Officer and President
BioInvent International AB
$2.5M
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
$11.5M
Tim Van Hauwermeiren MSc, EMBAChief Executive Officer and Executive Director
arGEN-X N.V
$320.6K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact PDL BioPharma, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.